Repare Therapeutics (RPTX) Income Statement: Revenue & Earnings

Repare Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Repare Therapeutics Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	53.48	51.13	131.83	7.60	0.14
Cost of Revenue	13.38	13.24	116.72	87.85	38.78
Gross Profit	40.10	37.89	15.11	-80.25	-38.64
Operating Expenses
Research & Development	100.03	117.96	119.07	90.05	0.00
Selling, General & Administrative	32.22	36.15	34.90	28.41	15.66
Operating Expenses	132.24	154.12	34.90	28.41	15.66
Operating Income	-92.14	-116.22	-19.80	-108.66	-54.30
Other Income/Expense
Interest Income	10.39	13.33	5.63	0.26	0.24
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-0.12	-0.12	-0.04	-0.04	-0.02
Income
Income Before Tax	-83.25	-103.18	-13.90	-108.59	-54.74
Income Tax Expense	1.44	-9.38	15.15	-1.68	-1.33
Net Income	-84.69	-93.80	-29.05	-106.91	-53.42
Net Income - Continuous Operations	-84.69	-93.80	-29.05	-106.91	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-90.22	-114.27	-17.82	-107.19	-53.41
EBIT	-92.14	-116.22	-19.80	-108.66	-54.30
Depreciation & Amortization	1.92	1.95	1.98	1.47	0.90
Earnings Per Share
Basic EPS	-2.00	-2.00	-1.00	-3.00	-3.00
Diluted EPS	-2.00	-2.00	-1.00	-3.00	-3.00
Basic Shares Outstanding	42.41	42.09	41.92	37.82	20.05
Diluted Shares Outstanding	42.41	42.09	41.92	37.82	20.05